People: Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

127.55EUR
29 Jun 2015
Change (% chg)

-- (--)
Prev Close
€127.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,339,511
52-wk High
€146.45
52-wk Low
€94.22

Search Stocks

Malik, Kemal 

Dr. Kemal Malik is Member of the Management Board responsible for Innovation and the North America region at Bayer AG effective February 1, 2014. Dr. Malik spent several years in clinical medicine at the Northwick Park Clinical Research Centre and at Hammersmith Hospital, London. He then held various positions in medical affairs and clinical development at Bristol-Myers Squibb in the United Kingdom. Dr. Malik joined Bayer in 1995 as Head of Metabolism and Oncology Europe in the then Pharmaceuticals Business Group. He subsequently served as Head of Global Medical Development before being appointed Head of Global Development. He was a member of the Executive Committee of Bayer HealthCare AG from July 1, 2007 until his appointment to the Board of Management of Bayer AG. He was also Head of Global Development and Chief Medical Officer in the Pharmaceuticals Division. He studied medicine at Charing Cross and Westminster Medical School (University of London), graduating as a Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1987.

Basic Compensation

Total Annual Compensation, EUR 659,000
Restricted Stock Awards, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 72,000
Fiscal Year Total, EUR 731,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Werner Wenning

370,000

Marijn Dekkers

1,405,410

Thomas de Win

247,000

Johannes Dietsch

262,000

Werner Baumann

1,239,000

Liam Condon

--
As Of  30 Dec 2014
Search Stocks